Eisai Clinical Trials

A Phase 2 Study of E7080 in Subjects With Advanced Thyroid Cancer

E7080-J081-208

Study Overview

E7080
lenvatinib
NCT01728623
Sep 2012 - Jul 2015
Thyroid Cancer
Not applicable

  • Age 18+ males and females

  • Completed

  • Phase 2

  • Japan

Results

CSR Synopsis

Download PDF

Lay Summary

No download available

Publication reference citation

Tahara M, Kiyota N, Yamazaki T, Chayahara N, Nakano K, Inagaki L, et al. Lenvatinib for Anaplastic Thyroid Cancer. Frontiers in oncology 2017 Mar 01;7:25. DOI: 10.3389/fonc.2017.00025

Data Sharing

ClinicalStudyDataRequest.com (CSDR) is a multi sponsor site through which qualified researchers who wish to access clinical trial data and associated information in order to conduct further research can submit their research proposal or enquiry.

Redacted documents are available upon request for this study.

Document type Availability
Protocol
SAP
Sample CRF
Full CSR